医用画像のインド市場の評価：製品別、用途別、エンドユーザー別、地域別、機会、予測（2018年度～2032年度）

インドの医用画像の市場規模は、2024年度の16億4,846万米ドルから2032年度に36億2,224万米ドルに達すると予測され、2025年度～2032年度の予測期間にCAGRで10.34％の成長が見込まれます。市場は、政府の取り組みや資金提供、老年人口の増加とそれに伴う慢性疾患の増加、先進技術を利用したシステムの採用の増加、医療アクセスの拡大、デジタルヘルスソリューションの統合、健康意識の高まり、戦略的パートナーシップ、償還政策の改善など、複数の要因によって牽引されています。これらの要因が相まって、先進の画像処理技術に対する需要が高まり、アクセシビリティが向上し、市場のダイナミックな成長と進化を促進しています。

医用画像は、正確な診断と効果的な治療計画をサポートする詳細な体内画像を提供することで、医療において不可欠な役割を果たしています。疾患の早期発見を容易にし、タイムリーな介入を可能にし、患者の転帰を大幅に改善します。さらに、医用画像診断は、疾病の進行の追跡や治療効果の評価において重要な役割を果たし、必要な変更を可能にします。技術の進歩により、CTや磁気共鳴画像法（MRI）のような高品質な画像の開発が可能になり、医師がより的確な診断を下せるようになったことが、医用画像市場を牽引しています。さらに、低所得の新興経済国を中心に、多くの先進国で病院支出が増加し、先進の画像技術が利用できるようになったことも、医療機器の需要を後押ししています。

例えば2024年5月、Fischer Medical Ventures Ltd.（FMVL）は、輸入機器への依存度を下げることを目指し、インドで初めてMRIシステムを国内で製造する企業になったことを発表しました。同社はインドのビシャカパトナムにあるAndhra Pradesh MedTech Zone（AMTZ）でMRI製造を展開しています。現在、インドの医療機器産業は輸入に大きく依存しており、推定では機器の80～85％が米国、欧州、中国から調達されています。

当レポートでは、インドの医用画像市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 インドの医用画像市場の見通し（2018年度～2032年度）

• 市場規模の分析と予測
  • 金額
  • 数量
• 市場シェアの分析と予測
  • 製品別
  • 用途別
  • エンドユーザー別
  • 地域別
  • 市場シェア分析：企業別（金額）（上位5社とその他 - 2024年度）
• 市場マップ分析（2024年度）
  • 製品別
  • 用途別
  • エンドユーザー別
  • 地域別

第5章 需給分析

第6章 輸入と輸出の分析

第7章 バリューチェーン分析

第8章 ポーターのファイブフォース分析

第9章 PESTLE分析

第10章 価格分析

第11章 市場力学

• 市場促進要因
• 市場の課題

第12章 市場の動向と発展

第13章 規制枠組みとイノベーション

• 規制当局の承認

第14章 特許情勢

第15章 ケーススタディ

第16章 競合情勢

• マーケットリーダー上位5社の競合マトリクス
• 上位5社のSWOT分析
• 上位10社の市場企業の主要企業の情勢
  • Wipro GE Healthcare Pvt. Ltd.
  • Siemens Healthcare Private Limited
  • Philips India Limited
  • Toshiba Medical Systems India Pvt. Ltd.
  • Hitachi Healthcare Manufacturing Ltd.
  • Mindray Medical India Pvt. Ltd.
  • Fujifilm India Pvt. Ltd.
  • Hologic India Pvt. Ltd.
  • Shanghai United Imaging Healthcare Co., LTD.
  • Agfa Healthcare India Pvt. Ltd.

第17章 戦略的推奨

第18章 当社について、免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Medical Imaging Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. India Medical Imaging Market, By Volume, In Million Units, FY2018-FY2032F
• Figure 3. India Medical Imaging Market Share (%), By Product, FY2018-FY2032F
• Figure 4. India Medical Imaging Market Share (%), By Application, FY2018-FY2032F
• Figure 5. India Medical Imaging Market Share (%), By End-user, FY2018-FY2032F
• Figure 6. India Medical Imaging Market Share (%), By Region, FY2018-FY2032F
• Figure 7. By Product Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 8. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 10. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024

India medical imaging market is projected to witness a CAGR of 10.34% during the forecast period FY2025-FY2032F, growing from USD 1,648.46 million in FY2024 to USD 3,622.24 million in FY2032. India medical imaging market is driven by several factors, which include government initiatives and funding, the growing geriatric population and subsequent rise in chronic diseases, increased adoption of technologically advanced systems, expanded healthcare access, integration of digital health solutions, growing healthcare awareness, strategic partnerships, and improved reimbursement policies. These factors collectively enhance the demand for advanced imaging technologies and improve accessibility, driving the dynamic growth and evolution of the market.

Medical imaging plays an essential role in healthcare by providing detailed internal images that support accurate diagnosis and effective treatment planning. It facilitates early detection of diseases, allowing for timely intervention and significantly improving patient outcomes. Moreover, medical imaging plays a crucial role in tracking how a disease develops and in evaluating how well treatments work, allowing for needed changes. Technological advancements have enabled the development of high-quality images such as CT and magnetic resonance imaging (MRI) that help doctors make better diagnoses, hence driving the medical imaging market. Furthermore, an increase in hospital expenditure and availability of advanced imaging technologies across many developed nations predominately among lower income developing economies would also fuel the demand for health equipment.

For instance, in May 2024, Fischer Medical Ventures Ltd. (FMVL) announced that it had become the first company in India to manufacture MRI systems domestically, aiming to reduce the country's reliance on imported devices. The company is developing its MRI manufacturing in the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam, India. Currently, the Indian medical device industry is heavily dependent on imports, with estimates indicating that 80-85% of devices are sourced from the United States, Europe, and China.

Increased Adoption of Technologically Advanced Systems

The expansion of India medical imaging market is primarily driven by the adoption of technologically advanced medical imaging systems. Combining 3D imaging with improved contemporary diagnosis tools, including high-resolution MRI and PET scans. Growing health consciousness in the population regarding early diagnosis and preventive care is likewise adding to the increasing necessity for cutting-edge imaging strategies. As technology becomes less expensive, an increasing number of healthcare providers can incorporate these advanced systems into their practices. The integration of AI-powered imaging solutions is transforming patient treatment as they provide more accurate analysis and predictive insights, which, in turn, improve patient outcomes. Further, the rapid shift towards telemedicine and remote diagnostic services is making advanced imaging technologies more accessible, especially to patients in rural and underserved communities. Cumulatively, these are propelling the growth of the Indian medical imaging market.

For instance, in July 2024, Philips India Limited, along with Star Imaging and Research Center, launched the country's first MRI training school. This partnership aims to provide world-class training in MRI modalities for 17 different sub-specialties focusing on the practical approach of imaging as per international standards.

Growing Geriatric Population and Subsequent Rise in Chronic Disease

Rising prevalence of chronic diseases is one of the key drivers in the medical imaging market in India. Moreover, there is a rising burden of chronic diseases that would necessitate further monitoring and follow-ups, thus increasing imaging demand. The prevalence of diseases including cardiovascular disorders, cancer, and diabetes is high, with a demographic shift towards the aging population, which mandates the use of advanced imaging equipment for effective diagnosis. Chronic disease diagnosis, detection, and evaluation requirements lead to more use of medical imaging equipment, such as MRI scanning systems, CT scan equipment systems, and ultrasound systems.

India is witnessing a major demographic change. As per the data published by NITI Aayog Government of India, the population aged 60 and above is projected to reach 158.7 million by 2025, making up 11.1% of the total population, and is projected to reach 19.5% of the total population by 2050. This swift growth presents a significant health challenge. Social-economic factors influence the likelihood of chronic conditions among older adults. Older adults with high educational attainment, urban residence status (i.e., living in an urban area), direct economic dependence, and lack of a spouse or children remain most at risk for chronic conditions, as well as those from higher-income families.

For instance, multimorbidity defined as the presence of two or more chronic conditions in an individual, is on the rise among the elderly in India. The Longitudinal Ageing Study of India (LASI) found that approximately 23% of the elderly population has multi-morbidities, with women being more likely to suffer from these conditions than men.

Oncology Segment Leads the Market Share in India Medical Imaging Market

Oncology is one of the key contributors to the India medical imaging market, supported by high cancer cases requiring advanced medical imaging, such as PET-CT, MRI and radiography. Government investments in healthcare infrastructure support the adoption of these technologies. India is facing a concerning rise in cancer cases, outpacing global averages and earning the troubling title of the "cancer capital of the world." A looming healthcare crisis further complicates this increase, as conditions like pre-diabetes, pre-hypertension, and mental health issues are increasingly being diagnosed among younger populations. For women, the most common cancers include breast, cervical, and ovarian cancers, while men are primarily affected by lung, mouth, and prostate cancers. A major concern is the significantly lower median age for cancer diagnosis in India compared to other nations, which emphasizes the urgent need for better early detection methods. The country, however, offers limited cancer screening services despite the high incidence rates, reflecting a significant gap in an important aspect of healthcare that needs to be addressed urgently.

For instance, according to the Health of Nation report published by Apollo Hospital in 2024, new cases of cancer are expected to increase faster than global averages, from 1.39 million in 2020 to an estimated 1.57 million by the end of 2024. In India, 40% of cases occur due to tobacco use, which increases the risk for lung, oral, and throat cancers, poor diet, and infrequent physical activity account for only 10%.

Northern India Dominates the India Medical Imaging Market

North India has become a favorable growth-boosting region due to numerous factors that contribute positively to the medical imaging market. Rising cases of chronic diseases and cancer, along with the development of urban localities, facilitate the demand for better diagnostic capabilities. Top cities like Delhi, Mumbai, and Chandigarh are enhancing medical services by adopting high-resolution MRI, CT scans, and PET scans in numerous hospitals and diagnostic centers. Moreover, the substantial investment in healthcare infrastructure development and modernization has been a boon for North India, with government and private players contributing actively. Telemedicine and remote diagnostic services are also gaining ground as they bring advanced imaging solutions to rural or underserved regions. Furthermore, the focus of many medical research institutes and educational centers in North India, such as AIIMS, New Delhi, encourages innovation.

For instance, in August 2023, Voxelgrids Innovations Pvt. Ltd. introduced an ultrafast 1.5 Tesla high field strength MRI system under the National Biopharma Mission of the Department of Biotechnology. This cutting-edge product is cost-effective and signals the next generation of selling magnetic resonance technology in India.

Future Market Scenario (FY2025-FY2032F)

The outlook for India medical imaging market is highly optimistic, fueled by several key factors that are expected to drive substantial growth. Currently, there is an annual demand for less than 350 MRI machines, but with rising healthcare awareness and government initiatives like Ayushman Bharat aimed at improving access and inclusivity, this demand is projected to become more than double by 2030. This surge is anticipated to significantly reduce MRI scanning costs for the general population while decreasing reliance on imported devices, thereby saving substantial foreign exchange.

For instance, in August 2024, the Government of India launched the Phased Manufacturing Programme (PMP), through which it offered a 20% capital subsidy for the domestic production of CT scans, digital X-rays, and MRI machines. This highlights the country's move towards domestic innovation and manufacturing. Collectively, these advancements and policies are set to drive the expansion of the medical imaging market in India, enhancing both accessibility and affordability.

Key Players Landscape and Outlook

India medical imaging market is quite competitive, with a major number of players at local levels as well. Regulatory approvals of company products, mergers and acquisitions, and collaborations are the most common market strategies that have been observed in recent times.

In June 2024, Fujifilm India's healthcare division, in partnership with NM Medical Mumbai, inaugurated its inaugural Fujifilm Skill Lab. This facility is dedicated to offering advanced training in full-field digital mammography (FFDM) technologies for radiologists and radiographers. The Fujifilm Mammography Skill Development Program aims to equip these professionals with the expertise needed to enhance their diagnostic capabilities and deliver superior patient care using Fujifilm's state-of-the-art mammography equipment.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India Medical Imaging Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. X-ray Devices
      • 4.2.1.1.1. Radiography
      • 4.2.1.1.2. Fluoroscopy
      • 4.2.1.1.3. Mammography
    • 4.2.1.2. Ultrasound
      • 4.2.1.2.1. Handheld
      • 4.2.1.2.2. Compact
    • 4.2.1.3. Computed Tomography (CT)
      • 4.2.1.3.1. High-End Slice CT
      • 4.2.1.3.2. Mid-End Slice CT
      • 4.2.1.3.3. Low-End Slice CT
      • 4.2.1.3.4. Cone Beam CT
    • 4.2.1.4. Magnetic Resonance Imaging (MRI)
      • 4.2.1.4.1. Closed System
      • 4.2.1.4.2. Open System
    • 4.2.1.5. Nuclear Imaging
      • 4.2.1.5.1. SPECT
      • 4.2.1.5.2. PET
  • 4.2.2. By Application
    • 4.2.2.1. Cardiology
    • 4.2.2.2. Oncology
    • 4.2.2.3. Neurology
    • 4.2.2.4. Orthopedics
    • 4.2.2.5. Gastroenterology
    • 4.2.2.6. Gynecology
    • 4.2.2.7. Others
  • 4.2.3. By End-use
    • 4.2.3.1. Hospitals
    • 4.2.3.2. Diagnostic Imaging Centers
    • 4.2.3.3. Others
  • 4.2.4. By Region
    • 4.2.4.1. North
    • 4.2.4.2. South
    • 4.2.4.3. East
    • 4.2.4.4. West and Central
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product
  • 4.3.2. By Application
  • 4.3.3. By End-user
  • 4.3.4. By Region

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

• 11.1. Market Drivers
• 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

• 13.1. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

• 16.1. Competition Matrix of Top 5 Market Leaders
• 16.2. SWOT Analysis for Top 5 Players
• 16.3. Key Players Landscape for Top 10 Market Players*
  • 16.3.1. Wipro GE Healthcare Pvt. Ltd.
    • 16.3.1.1. Company Details
    • 16.3.1.2. Key Management Personnel
    • 16.3.1.3. Products and Services
    • 16.3.1.4. Financials (As Reported)
    • 16.3.1.5. Key Market Focus and Geographical Presence
    • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 16.3.2. Siemens Healthcare Private Limited
  • 16.3.3. Philips India Limited
  • 16.3.4. Toshiba Medical Systems India Pvt. Ltd.
  • 16.3.5. Hitachi Healthcare Manufacturing Ltd.
  • 16.3.6. Mindray Medical India Pvt. Ltd.
  • 16.3.7. Fujifilm India Pvt. Ltd.
  • 16.3.8. Hologic India Pvt. Ltd.
  • 16.3.9. Shanghai United Imaging Healthcare Co., LTD.
  • 16.3.10. Agfa Healthcare India Pvt. Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer